Persistent Systems Limited (NSE:PERSISTENT)
India flag India · Delayed Price · Currency is INR
5,061.50
-99.00 (-1.92%)
Aug 1, 2025, 3:30 PM IST

Revance Therapeutics Revenue

Persistent Systems had revenue of 33.34B INR in the quarter ending June 30, 2025, with 21.79% growth. This brings the company's revenue in the last twelve months to 125.35B, up 22.44% year-over-year. In the fiscal year ending March 31, 2025, Persistent Systems had annual revenue of 119.39B with 21.56% growth.

Revenue (ttm)
125.35B
Revenue Growth
+22.44%
P/S Ratio
6.03
Revenue / Employee
5.65M
Employees
22,205
Market Cap
755.43B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025119.39B21.17B21.56%
Mar 31, 202498.22B14.71B17.62%
Mar 31, 202383.51B26.40B46.23%
Mar 31, 202257.11B15.23B36.36%
Mar 31, 202141.88B6.22B17.45%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition